BioNTech and Pfizer will today submit an emergency approval request to the FDA for a COVID-19 vaccine. Companies are also preparing to apply to regulatory authorities in other countries, including Australia, Canada, Europe, Japan and the United Kingdom. The partners expect to produce up to 50 million doses in 2020 and up to 1.3 billion by the end of 2021.
BioNTech and Pfizer will today submit an emergency approval request to the FDA for a COVID-19 vaccine. Companies are also preparing to apply to regulatory authorities in other countries, including Australia, Canada, Europe, Japan and the United Kingdom. The partners expect to produce up to 50 million doses in 2020 and up to 1.3 billion by the end of 2021. 
investors.biontech.de
English (US) 